COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,364 Articles (22,803 medRxiv, 8,561 bioRxiv)

Most recent first Previous |  Page 160: Articles 1591-1600  | Next

Enhanced immune evasion of SARS-CoV-2 KP.3.1.1 and XEC through NTD glycosylation
Liu, J., Yu, Y., Jian, F., Yang, S., Song, W., Wang, P., Yu, L., Shao, F., Cao, Y.
10.1101/2024.10.23.619754 — Posted: 2024-10-23
Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccination
Aamodt, A. H., Ueland, T., Boldingh, M., Bezgal, B. E., Argren, M., Dunne, C. A., Otterdal, K., Gregersen, I., Bjerkeli, V., Michelsen, A. E., Husoey, A., Morsund, A. H., Devik, K., Poole, A. C., Gjendemsjoe, K. B., Schluter, K., Mathisen, S. M., Aalstad-Johansen, M., Skattoer, T. H., Soennervik, J., Boye, T. B., Popperud, T. H., Hoegestoel, E. A., Lund-Johansen, F., Aukrust, P., Tronvik, E., Dahl, T. B., Halvorsen, B.
10.1101/2024.10.19.24315794 — Posted: 2024-10-22
Predictive model for real-world performance of COVID-19 antigen tests based on laboratory evaluation
Bosch, M. E., Garcia, D., Rudtner, L., Salcedo, N., Colmenares, R., Hoche, S., Arocha, J. G., Hall, D., Moreno, A., Bosch, I.
10.1101/2024.10.21.24315762 — Posted: 2024-10-22
Transmission of SARS-CoV-2 on aircraft: A scoping review
Vardavas, C. I., Nikitara, K., Aslanoglou, K., Kamekis, A., Ramesh, N., Symvoulakis, E., Phalkey, R., Leonardi-Bee, J., Mouchtouri, V., Hadjichristodoulou, C., Baka, A., Lamb, F., Suk, J. E., Robesyn, E.
10.1101/2024.10.22.24315911 — Posted: 2024-10-22
Fear of COVID-19 after vaccination dissemination and its relationship with multidimensional health literacy among patients on maintenance haemodialysis
Kawaji, A., Inanaga, R., Ukai, M., Aita, T., Kanakubo, Y., Toishi, T., Matsunami, M., Toida, T., Munakata, Y., Okada, T., Suzuki, T., Kurita, N.
10.1101/2024.10.19.24315821 — Posted: 2024-10-22
Elevated Liver Damage Biomarkers in Long COVID: A Systematic Review and Meta-Analysis.
Almulla, A. F., Thipakorn, Y., Zhang, Y., Maes, M.
10.1101/2024.10.18.24315698 — Posted: 2024-10-22
Interferon-mediated NK cell activation is associated with limited neutralization breadth during SARS-CoV-2 infection
de los Rios Kobara, I., Jayewickreme, R., Lee, M. J., Wilk, A. J., Stanford COVID-19 Biobank, , Blomkalns, A. L., Nadeau, K. C., Yang, S., Rogers, A. J., Blish, C. A.
10.1101/2024.10.22.619639 — Posted: 2024-10-22
Engineered protein destabilization reverses intrinsic immune evasion for candidate vaccine pan-strain KSHV and SARS-CoV-2 antigens
Wan, L., Xie, B., Shuda, M., Delgoffe, G. M., Chang, Y., Moore, P. S.
10.1101/2024.10.22.619692 — Posted: 2024-10-22
Inter-laboratory harmonization of microsphere immunoassays for SARS-CoV-2 antibody detection in dried blood spots and oral fluids
DeRosa, K. L., Pisanic, N., Kruczynski, K., Heaney, C. D., Styer, L. M., MANTIS, N. J.
10.1101/2024.10.19.619238 — Posted: 2024-10-22
Oxytocin-mediated social preference and socially reinforced reward learning in the miniature fish Danionella cerebrum
Penalva, A., Bedke, J., Gaudin, A., Barrios, J. P., Bertram, E. P. L., Douglass, A. D.
10.1101/444026 — Posted: 2024-10-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).